Annual EBITDA
$187.38M$148.21M+378.38%
Summary
- Current Value
- As of today, AVAH annual EBITDA is $187.38M, up +378.38% on
- Historical Performance
- AVAH annual EBITDA is up +1143.59% over the past 3 years, and up +323.17% over the past 5 years
- All-Time High Comparison
- AVAH annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- AVAH annual EBITDA is +135.69% above its 3-year low of -$525.06M reached on an earlier date
- Sector Comparison
- AVAH annual EBITDA is higher than 88.11% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $187.38M | +378.4% | +1143.6% | +323.2% | +395.4% | |
| Quarterly EBITDA | $63.40M | +42.6% | +212.1% | +241.4% | -5.6% | |
| TTM EBITDA | $266.99M | +61.0% | +103.8% | +623.7% | +297.7% | |
| Price | $8.59 | +83.9% | +794.8% | – | – | |
| PE Ratio | 23.86 | – | – | – | – | |
| Annual Revenue | $2.02B | +6.8% | +20.6% | +46.3% | +61.5% | |
| Annual EPS | -$0.06 | +92.0% | +91.0% | +86.2% | +77.6% | |
| Annual EBIT | $156.21M | +1622.1% | +392.8% | +804.8% | +503.5% | |
| Annual Net Income | -$10.93M | +91.9% | +90.7% | +85.7% | +76.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $187.38M | at high | |
| 5Y | $187.38M | at high | |
| All | $187.38M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$525.06M | N/A | +135.7% |
| 5Y | -$525.06M | +135.7% | |
| All | -$525.06M | +135.7% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $187.38M | +378.4% | |
| $39.17M | +107.5% | |
| -$525.06M | -2,824.3% | |
| -$17.96M | -129.2% |
| Year | Value | Change |
|---|---|---|
| $61.47M | +38.8% | |
| $44.28M | +17.1% | |
| $37.82M | - |
FAQ
What is the current annual EBITDA of AVAH?
As of today, AVAH annual EBITDA is $187.38M
What is 1-year change in AVAH annual EBITDA?
AVAH annual EBITDA is up +378.38% year-over-year
What is 3-year change in AVAH annual EBITDA?
AVAH annual EBITDA is up +1143.59% over the past 3 years
How far is AVAH annual EBITDA from its all-time high?
AVAH annual EBITDA is currently at its all-time high
How does AVAH annual EBITDA rank versus sector peers?
AVAH annual EBITDA is higher than 88.11% of companies in Healthcare sector
When is AVAH next annual earnings release?
The next annual earnings release for AVAH is on
Quarterly EBITDA
$63.40M$23.98M-27.44%
Summary
- Current Value
- As of today, AVAH quarterly EBITDA is $63.40M, down -27.44% on
- Historical Performance
- AVAH quarterly EBITDA is up +42.64% year-over-year, and up +212.07% over the past 3 years
- All-Time High Comparison
- AVAH quarterly EBITDA is currently -27.44% below its historical high of $87.38M set on
- 3-Year Low Comparison
- AVAH quarterly EBITDA is +119.42% above its 3-year low of $28.89M reached on an earlier date
- Sector Comparison
- AVAH quarterly EBITDA is higher than 86.61% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $63.40M | -27.4% | +42.6% | +212.1% | +241.4% | |
| Annual EBITDA | $187.38M | – | +378.4% | +1143.6% | +323.2% | |
| TTM EBITDA | $266.99M | +7.6% | +61.0% | +103.8% | +623.7% | |
| Price | $8.59 | -2.5% | +83.9% | +794.8% | – | |
| PE Ratio | 23.86 | -2.5% | – | – | – | |
| Quarterly Revenue | $621.94M | +5.5% | +22.2% | +40.4% | +69.9% | |
| Quarterly EPS | $0.06 | -50.7% | +128.6% | -51.5% | +254.0% | |
| Quarterly EBIT | $56.27M | -30.0% | +51.7% | +408.0% | +402.8% | |
| Quarterly Net Income | $14.06M | -48.0% | +132.8% | -42.1% | +290.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $87.38M | -27.4% | |
| 3Y | $87.38M | -27.4% | |
| 5Y | $87.38M | -27.4% | |
| All | $87.38M | -27.4% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $55.64M | N/A | +13.9% |
| 3Y | $28.89M | N/A | +119.4% |
| 5Y | $20.32M | +212.1% | |
| All | -$48.81M | +229.9% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of AVAH?
As of today, AVAH quarterly EBITDA is $63.40M
What is AVAH quarterly EBITDA most recent change?
AVAH quarterly EBITDA was down -27.44% on September 27, 2025
What is 1-year change in AVAH quarterly EBITDA?
AVAH quarterly EBITDA is up +42.64% year-over-year
How far is AVAH quarterly EBITDA from its all-time high?
AVAH quarterly EBITDA is currently -27.44% below its historical high of $87.38M set on June 28, 2025
How does AVAH quarterly EBITDA rank versus sector peers?
AVAH quarterly EBITDA is higher than 86.61% of companies in Healthcare sector
When is AVAH next earnings release?
The next earnings release for AVAH is on
TTM EBITDA
$266.99M$18.95M+7.64%
Summary
- Current Value
- As of today, AVAH TTM EBITDA is $266.99M, up +7.64% on
- Historical Performance
- AVAH TTM EBITDA is up +60.99% year-over-year, and up +103.84% over the past 3 years
- All-Time High Comparison
- AVAH TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- AVAH TTM EBITDA is +139.04% above its 3-year low of $111.69M reached on
- Sector Comparison
- AVAH TTM EBITDA is higher than 87.42% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $266.99M | +7.6% | +61.0% | +103.8% | +623.7% | |
| Annual EBITDA | $187.38M | – | +378.4% | +1143.6% | +323.2% | |
| Quarterly EBITDA | $63.40M | -27.4% | +42.6% | +212.1% | +241.4% | |
| Price | $8.59 | -2.5% | +83.9% | +794.8% | – | |
| PE Ratio | 23.86 | -2.5% | – | – | – | |
| TTM Revenue | $2.29B | +5.2% | +15.5% | +30.9% | +113.5% | |
| TTM EPS | $0.36 | +379.4% | +204.7% | +112.1% | +237.0% | |
| TTM EBIT | $238.75M | +8.7% | +77.2% | +158.6% | +1538.7% | |
| TTM Net Income | $75.46M | +306.7% | +214.6% | +113.7% | +259.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $266.99M | at high | |
| 3Y | $266.99M | at high | |
| 5Y | $266.99M | at high | |
| All | $266.99M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $182.04M | N/A | +46.7% |
| 3Y | $111.69M | +139.0% | |
| 5Y | $38.24M | +598.2% | |
| All | $18.32M | +1357.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of AVAH?
As of today, AVAH TTM EBITDA is $266.99M
What is AVAH TTM EBITDA most recent change?
AVAH TTM EBITDA was up +7.64% on September 27, 2025
What is 1-year change in AVAH TTM EBITDA?
AVAH TTM EBITDA is up +60.99% year-over-year
How far is AVAH TTM EBITDA from its all-time high?
AVAH TTM EBITDA is currently at its all-time high
How does AVAH TTM EBITDA rank versus sector peers?
AVAH TTM EBITDA is higher than 87.42% of companies in Healthcare sector
When is AVAH next earnings release?
The next earnings release for AVAH is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- AVAH Official Website www.aveanna.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1832332/000119312525267978/0001193125-25-267978-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1832332/000095017025038504/0000950170-25-038504-index.htm
- AVAH Profile on Yahoo Finance finance.yahoo.com/quote/AVAH
- AVAH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/avah